MRK
Merck & Co., Inc. · Healthcare
EVP and CHRO Steven Mizell sold $3.5M of Merck & Co., Inc.
Sold$3,541,278
$101.18Price
35,000Shares
−52%Stake
What MRK did after the filing
- The stock from Fri, Nov 11 open, $100.53
- +11.5%
- S&P 500, same days
- −3.1%
Measured over 30 trading days, to the Dec 27 close.
Traded Tue, Nov 8. Filed Thu, Nov 10, 5:01 PM ET, after the close. Returns use the Nov 11 open and the Dec 27 close. Not investment advice.